LUNA Up 6.49% as Binance Announces Network Upgrade

Generated by AI AgentCryptoPulse AlertReviewed byAInvest News Editorial Team
Friday, Dec 5, 2025 12:55 am ET1min read
Aime RobotAime Summary

- Binance suspends LUNA deposits/withdrawals from Dec. 8 to support Terra’s network upgrade, ensuring security during transition.

- LUNA’s 6.49% 24-hour price surge reflects renewed investor confidence despite temporary liquidity constraints.

- Separate biotech trial named “LUNA” shows 90% reduced injections for

, with no new safety issues in two-year data.

- Binance’s maintenance announcement has not triggered major volatility, with market viewing it as routine operational adjustment.

Binance Suspends LUNA Deposits and Withdrawals Ahead of Network Upgrade

On Dec. 5, 2025, Binance announced that it will suspend

(LUNA) token deposits and withdrawals at 20:05 UTC+8 on Dec. 8 to support the Terra network’s scheduled upgrade. This maintenance window aligns with a critical block height target of 18,660,000, expected to be reached at 21:05 UTC+8 on the same day. The exchange emphasized that this temporary halt is necessary to ensure the security and continuity of the protocol during the transition. Investors and traders are advised to monitor Binance’s official channels for updates following the completion of the upgrade.

LUNA’s Performance Reflects Investor Confidence

Despite the suspension of deposit and withdrawal services for a few hours, LUNA’s price surged by 6.49% within 24 hours as of Dec. 5, 2025, reaching $0.0788. Over the past week and month, the token saw similar gains of 9.14%, reflecting renewed investor interest in the Terra ecosystem. The price increase stands in contrast to its 81% decline over the past year, suggesting a short-term stabilization in sentiment among market participants. Analysts project that the network upgrade could further bolster confidence in the platform’s long-term viability, though no guarantees are made regarding future price movements.

Separate Biotechnology Trial Named ‘LUNA’ Generates Positive Results

Separately, on Dec. 4, Adverum Biotechnologies, Inc. announced two-year data from its Phase 2

trial for Ixo-vec in the treatment of wet age-related macular degeneration (AMD). The trial demonstrated a nearly 90% reduction in anti-VEGF injections over two years, with sustained anatomic and visual outcomes across both dose groups. The 6E10 dose group also reported no new inflammation after week 30. Enrollment in the Phase 3 ARTEMIS trial is expected to be completed by Dec. 5, 2025. Ixo-vec has continued to demonstrate a favorable safety profile, with no new safety signals emerging. This development is unrelated to the Terra cryptocurrency LUNA but shares the same name in the biotech sector.

No Market Impact from Binance’s LUNA Maintenance Announcement

The maintenance notice from Binance has not triggered significant volatility beyond the already observed upward trend. While the suspension of deposit and withdrawal services may temporarily affect liquidity for some traders, the broader market appears to have priced in the event as a routine operational adjustment. Binance has previously carried out similar pauses for network upgrades without triggering major market reactions. The focus remains on the success of the upgrade itself, which is expected to enhance the Terra network’s functionality and security.

Comments



Add a public comment...
No comments

No comments yet